The heart in polyarteritis nodosa

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search
The heart in polyarteritis nodosa
Classification and external resources

Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology

WikiDoc Resources for

The heart in polyarteritis nodosa

Articles

Most recent articles on The heart in polyarteritis nodosa

Most cited articles on The heart in polyarteritis nodosa

Review articles on The heart in polyarteritis nodosa

Articles on The heart in polyarteritis nodosa in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on The heart in polyarteritis nodosa

Images of The heart in polyarteritis nodosa

Photos of The heart in polyarteritis nodosa

Podcasts & MP3s on The heart in polyarteritis nodosa

Videos on The heart in polyarteritis nodosa

Evidence Based Medicine

Cochrane Collaboration on The heart in polyarteritis nodosa

Bandolier on The heart in polyarteritis nodosa

TRIP on The heart in polyarteritis nodosa

Clinical Trials

Ongoing Trials on The heart in polyarteritis nodosa at Clinical Trials.gov

Trial results on The heart in polyarteritis nodosa

Clinical Trials on The heart in polyarteritis nodosa at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on The heart in polyarteritis nodosa

NICE Guidance on The heart in polyarteritis nodosa

NHS PRODIGY Guidance

FDA on The heart in polyarteritis nodosa

CDC on The heart in polyarteritis nodosa

Books

Books on The heart in polyarteritis nodosa

News

The heart in polyarteritis nodosa in the news

Be alerted to news on The heart in polyarteritis nodosa

News trends on The heart in polyarteritis nodosa

Commentary

Blogs on The heart in polyarteritis nodosa

Definitions

Definitions of The heart in polyarteritis nodosa

Patient Resources / Community

Patient resources on The heart in polyarteritis nodosa

Discussion groups on The heart in polyarteritis nodosa

Patient Handouts on The heart in polyarteritis nodosa

Directions to Hospitals Treating The heart in polyarteritis nodosa

Risk calculators and risk factors for The heart in polyarteritis nodosa

Healthcare Provider Resources

Symptoms of The heart in polyarteritis nodosa

Causes & Risk Factors for The heart in polyarteritis nodosa

Diagnostic studies for The heart in polyarteritis nodosa

Treatment of The heart in polyarteritis nodosa

Continuing Medical Education (CME)

CME Programs on The heart in polyarteritis nodosa

International

The heart in polyarteritis nodosa en Espanol

The heart in polyarteritis nodosa en Francais

Businness

The heart in polyarteritis nodosa in the Marketplace

Patents on The heart in polyarteritis nodosa

Experimental / Informatics

List of terms related to The heart in polyarteritis nodosa

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Associate Editor: Cafer Zorkun, M.D., Ph.D. [2] Phone:617-525-7431

Cardiology Network

Discuss The heart in polyarteritis nodosa further in the WikiDoc Cardiology Network
Adult Congenital
Biomarkers
Cardiac Rehabilitation
Congestive Heart Failure
CT Angiography
Echocardiography
Electrophysiology
Cardiology General
Genetics
Health Economics
Hypertension
Interventional Cardiology
MRI
Nuclear Cardiology
Peripheral Arterial Disease
Prevention
Public Policy
Pulmonary Embolism
Stable Angina
Valvular Heart Disease
Vascular Medicine
WikiDoc Cardiology News

Read more about The heart in polyarteritis nodosa in the WikiDoc Cardiology News
All News Articles
Acute Coronary Syndromes
Biomarkers
Cardiovascular Imaging
CT Surgery
Diabetes
Electrophysiology
General Cardiology
Guidelines
Health Policy
Heart Failure
Hypertension
Interventional
Peripheral Arterial Disease
Prevention
Valvular Heart Disease

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

The heart and coronary arteries are infrequently involved in polyarteritis nodosa. Most often this involvement is a vasculitis of the distal subepicardial coronary arteries just as they penetrate the myocardium. The lesions are characterized by inflammatory infiltrates in the media and adventitia and occasionally by necrosis of the full thickness of the vessel wall, with prominent involvement of the surrounding perivascular connective tissue.

The lumens of the involved vessels may contain thrombi, and the walls may be aneurysmal. The latter is responsible for the nodular appearance of the arteries deemed characteristic of this disorder. An even later stage of the vasculitis process is evident as the lesions heal, first showing the formation of granulation tissue and subsequently fibrous tissue replacement of the original components of the artery. In this healing phase, intimal proliferation leading to coronary artery luminal narrowing is evident.

The coronary artery disease of Polyarteritis Nodosa may lead to myocardial infarction. The myocardial necrosis and subsequent replacement fibrosis tend to be focal and patchy throughout the left ventricular wall. This is in contrast to the large areas of grossly visible, regional, subendocardial, or transmural necrosis typically seen in the myocardial infarction caused by Coronary Artery Disease.

Conduction system abnormalities have been identified in the heart of patients with Polyarteritis Nodosa. The size and location of the sinoatrial node and atrioventricular node arteries make them prime targets for polyarteritis. Atrial and ventricular conduction disturbances may be a primary manifestation of Polyarteritis Nodosa, despite minimal involvement of vessels elsewhere in the heart.

Other cardiac abnormalities seen in patients with Polyarteritis Nodosa are those that are likely secondary to the underlying systemic arterial hypertension and renal disease.

Cardiomegaly and left ventricular hypertrophy most often represent secondary cardiac manifestations of this disease. Similarly, pericardial disease may develop in a patient with Polyarteritis Nodosa, but this is most often due to renal insufficiency.[1] [1] [1] [1] [1] [1]

Clinical Manifestations

Despite the dramatic involvement of coronary arteries that may accompany Polyarteritis Nodosa, the most frequent cardiovascular abnormalities seen in patients with Polyarteritis Nodosa are unrelated to the coronary arteries per se.

Systemic arterial hypertension occurs in approximately 90% of these patients and, in combination with chronic renal failure, is the most likely cause of congestive heart failure, which may develop in up to 60% of patients. Those with Polyarteritis Nodosa also may develop acute myocardial infarction, which poses the diagnostic question of whether the myocardial injury is due to coronary arteritis with secondary thrombosis or to atherosclerosis, in a population that is typically middle-aged, male, steroid treated, and susceptible to atherosclerotic coronary artery disease as well. [1] [1] [1] [1] [1] [1]

Treatment

Polyarteritis Nodosa has a poor prognosis. Treatment of the heart disease in Polyarteritis Nodosa is directed at the specific cardiac dysfunction. Glucocorticoids are still the initial mainstay of therapy. Early use of cyclophosphamide in severe disease with involvement of major organs has been associated with decreased mortality.

Case reports of improvement of hepatitis B virus related Polyarteritis Nodosa with concomitant immunosuppressive and antiviral therapy are encouraging.

The use of warfarin remains controversial; low dose aspirin, however, is usually recommended. [1]

A Case Example

Clinical Summary

A 27-year-old white female who presented to the emergency room with fever, diarrhea, and abdominal pain that had increased in intensity over a 3-day period. Her blood pressure on admission was 165/108 mm Hg.

She had been diagnosed with polyarteritis nodosa two years prior to this admission and had been treated with corticosteroids and cyclophosphamide. She had discontinued her corticosteroids because they made her gain weight; in addition, she was not taking the medications prescribed for her hypertension. At this admission it was suspected that the patient had bowel ischemia due to mesenteric artery occlusion.

Angiographic evaluation revealed significant vascular damage to the mesenteric arteries with aneurysmal dilatations and thromboses. Significant vascular changes were also observed in the renal and hepatic circulation.

On the second hospital day, the patient developed acute severe abdominal pain and an emergency laparotomy was performed to resect an 18-cm section of infarcted and ruptured ileum.

After surgery she continued to run a fever, her white blood cell count was 13,500 cells/cmm, and she developed renal failure. Two days after surgery the patient died due to sepsis and multisystem failure.

Histopathological Findings

At autopsy there were several 0.5 to 1.0-cm firm nodules in the dermis. There were numerous aneurysmal dilatations grossly visible in the mesenteric arteries. There were multiple shrunken infarcts on the surface of the kidneys and the surface also had a fine granular appearance indicative of hypertensive renal disease. On cut section both the kidney and the liver had multiple firm white nodules.

Images courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology






References

WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools
Navi